Skip to main content
SpringerLink
Log in

Severe mucitis after sublingual administration of tetrahydrobiopterin in a patient with tetrahydrobiopterin-responsive phenylketonuria

  • Short Report
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Bernegger C, Blau N (2002) High frequency of tetrahydrobiopterin-responsiveness among hyperphenylalaninemias: a study of 1919 patients observed from 1988 to 2002. Mol Genet Metab 77: 304–313

    Google Scholar 

  2. Blau N, Erlandsen H (2004) The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab 82: 101–111

    Google Scholar 

  3. Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriouniv D, Schircks B, Thöny B, Blau N (2004) Plasma tetrahydrobiopterin and its pharmacokinetics following oral administration. Mol Genet Metab 81: 45–51

    Google Scholar 

  4. Kure S, Hou DC, Ohura T, Iwamoto H, Suzuki S, Sugiyama N, Sakamoto O, Fujii K, Matsubara Y, Narisawa K (1999) Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J Pediatr 135: 375–378

    Google Scholar 

  5. Muntau AC, Roschinger W, Habich M, Demmelmair H, Hoffmann B, Sommerhoff CP, Roscher AA (2002) Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med 347: 2122–2132

    Google Scholar 

  6. Thöny B, Ding Z, Martinez A (2004) Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia. FEBS Lett 577: 507–511

    Google Scholar 

Download references

Acknowledgements

The authors thank the patient and his family for their exemplary participation. This work was supported by the Swiss National Science Foundation grant no. 3100-066953.01. Thomas Opladen received a research grant from the Aachen Medical Faculty and support from the “Sanitätsrat-Dr.-Emil-Alexander-Huebner-und Gemahlin-Stiftung”.

Author information

Authors and Affiliations

  1. Division of Clinical Chemistry and Biochemistry, University Children’s Hospital, Steinwiesstrasse 75, 8032 , Zurich, Switzerland

    Thomas Opladen, Marcel Zurflüh, Lucja Kierat, Beat Thöny & Nenad Blau

  2. Division of Paediatric Neurology, Department of Paediatrics, University Hospital, Aachen, Germany

    Thomas Opladen

  3. Division of Metabolism, Department of Paediatrics, University Hospital, Geneva, Switzerland

    Ilse Kern

Authors
  1. Thomas Opladen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcel Zurflüh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilse Kern
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lucja Kierat
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Beat Thöny
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nenad Blau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nenad Blau.

Additional information

The first two authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Opladen, T., Zurflüh, M., Kern, I. et al. Severe mucitis after sublingual administration of tetrahydrobiopterin in a patient with tetrahydrobiopterin-responsive phenylketonuria. Eur J Pediatr 164, 395–396 (2005). https://doi.org/10.1007/s00431-005-1638-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-005-1638-7

Keywords

Search

Navigation